Asthma and Asthma Medication Are Common among Recreational Athletes Participating in Endurance Sport Competitions
Table 3
Self-reported frequency of asthma medication use among Swedish competitive recreational athletes with self-reported asthma, that is, physician diagnosis of asthma and use of asthma medication during the last 12 months, in each of the competitions and pooled data.
Never
Sometimes
<2 months
>2 months
Daily
CCR Lidingöloppet
SABA/LABA
98 (15)
295 (44)
40 (6)
83 (12)
154 (23)
ICS
319 (48)
96 (15)
41 (6)
40 (6)
166 (25)
ICS + LABA
439 (67)
34 (5)
16 (2)
26 (4)
139 (21)
CCS Vasaloppet
SABA/LABA
53 (16)
178 (52)
15 (4)
31 (9)
64 (19)
ICS
182 (55)
53 (16)
18 (5)
19 (6)
62 (18)
ICS + LABA
203 (60)
22 (7)
9 (3)
9 (3)
93 (28)
OWS Vansbrosimningen
SABA/LABA
22 (10)
99 (45)
15 (7)
21 (10)
63 (29)
ICS
97 (46)
19 (9)
8 (4)
8 (4)
79 (37)
ICS + LABA
148 (69)
7 (3)
3 (1)
3 (1)
52 (24)
Pooled study population
SABA/LABA
167 (15)
531 (46)
67 (6)
126 (11)
259 (22)
ICS
563 (50)
153 (14)
64 (6)
63 (5)
283 (25)
ICS + LABA
736 (66)
61 (6)
27 (3)
36 (3)
262 (23)
SABA = short-acting beta-2-agonists; LABA = long-acting beta-2-agonists; ICS = inhaled corticosteroids. Data are presented as (%).
